Background: Effects of nonparoxysmal atrial fibrillation (non-PAF) ablation targeting
clinical study, the STAR AF II, 3 showed that a CFAE-targeted ablation after a PVI has no apparent additional benefit in patients with non-PAF.
As an alternative ablation strategy for non-PAF, ablation targeting low voltage areas (LVAs) detected by voltage mapping during sinus rhythm or coronary sinus pacing has been proposed. 4 However, because such an indirect indicator of AF drivers is not based on the excitation wave dynamics during AF, the relationship of the LVA to the location of the real AF drivers is still unclear.
For these reasons, real-time imaging of AF wave dynamics in clinical practice is required for detecting real AF drivers and improving the outcome of the non-PAF ablation. Thus, the goals of this study were to visualize the excitation wave dynamics during AF in patients with non-PAF by employing our novel online real-time phase mapping system and to investigate whether the above-mentioned indirect indicators really reflected the real AF drivers.
2 | ME TH ODS
| Novel real-time phase mapping system
We have developed an online real-time phase mapping system (ExTRa Mapping TM , Nihon Kohden Co., Tokyo, Japan), as shown in To improve the detection and spatiotemporal interpolation of the intra-atrial signals and to achieve a rapid prediction of the atrial excitations during AF, both computer simulation (in silico) part and specialized artificial intelligence part were incorporated into the system.
Combined with the timing of the action potential onset determined by the intra-atrial signals, the in silico part calculated the virtual atrial action potentials based on the in silico model of human non-PAF. 5 Therefore, the virtual action potentials during non-PAF could faithfully reproduce the restitution properties of human atria under structural remodeling.
| Patient characteristics and study protocol
Forty-nine consecutive patients with non-PAF scheduled to undergo catheter ablation in the Shiga University of Medical Science hospital were enrolled in this study. Then, ExTRa Mapping was applied to the patients with non-PAF if AF inducibility was confirmed after the PVI. Antiarrhythmic drugs, except for amiodarone, were discontinued at least 3 weeks before the ablation, and no antiarrhythmic drugs were added after the ablation. Informed consent was obtained from each patient and was approved by the ethics committee in Shiga University of Medical Science.
Then, in the whole left atrium (LA) during AF, phase mapping using the ExTRa Mapping and CFAE mapping using the electro-anatomical mapping 3D navigation system (EnSite NavX TM , St. Jude Medical Inc., MN, USA) were performed simultaneously. To avoid the excess overlap of the ExTRa Mapping regions, the CFAE mapping was conducted simultaneously. As for the CFAE mapping, a definition of the excitation cycle length of below 120 ms was employed.
To rapidly find the location of non-PAF drivers, nonpassively activated areas (NPAs), in which rotational activations were frequently observed, were automatically detected by the ExTRa Mapping. In this study, the NPAs in each patient were determined according to the value of the "nonpassively activated ratio (%NP)"
(the ratio of the nonpassively activated period to the recording time)
automatically calculated based on the 5-second real-time phase map movies created by the ExTRa Mapping.
Also voltage mapping after the electrical cardioversion was performed in the same patients with non-PAF. In this study, the LVA F I G U R E 1 Novel online real-time phase mapping system (ExTRa Mapping TM ). Intraatrial bipolar electrograms recorded by a 20-pole spiral-shaped catheter during atrial fibrillation (AF) in patients with nonparoxysmal AF (non-PAF) are transferred into an in silico analysis system to calculate virtual action potentials and phase values. Then, the mapping system combines the intra-atrial bipolar electrograms with the virtual action potentials to create spatial phase map movies within a few seconds. Snapshots of the typical non-PAF wave dynamics visualized by the ExTRa Mapping are shown in the top right 3 panels was defined as an area, of which the intra-atrial bipolar signal amplitude was below 0.5 mV. For the pacing sites, coronary sinus distal and proximal parts, superior vena cava, and lower lateral wall of right atrium were employed.
| Evaluation of the outcome of non-PAF ablation
After the ablation, the patients were monitored every 1-3 months using the 12-lead ECG and the event ECG monitors for 2-4 weeks.
AF recurrence was defined as AF of duration ≥30 seconds was documented more than several times after the 3-month blanking period.
To evaluate the outcome of non-PAF ablation with a KaplanMeier estimate, EZR software 6 was employed.
3 | RESULTS
| Clinical characteristics
The clinical characteristics of all 49 consecutive non-PAF patients and of the 28 non-PAF patients with AF inducibility after PVI are shown in Table 1 In this case, voltage mapping ( Figure 4A ) was conducted before PVI because the AF was terminated by electrical cardioversion. After the PVI followed by CTI ablation, the AF inducibility was confirmed by burst pacing, and simultaneous ExTRa and CFAE mapping was conducted ( Figure 4B ). 
| Case 4: Long-standing persistent AF
Case 4 was a 65-year-old male with non-PAF duration of 1.5 years.
Voltage mapping was performed after 2 repeated 20-J cardioversions, and then, PVI was conducted. Simultaneous ExTRa and CFAE mapping was performed after the AF induction because the AF inducibility was confirmed after the PVI.
Four of the 5 NPAs (areas with the top 5 highest %NP values)
partially overlapped with LVAs ( Figure 5A ), whereas only 1 of the 5
NPAs overlapped with obvious CFAE areas ( Figure 5B ). Figure 5C is a snapshot of the phase map movie (Video S4) of the NPA where that neither overlapped with LVAs nor CFAE areas. In the NPA, following 3 passive excitation waves, counterclockwise rotational activations were observed and followed by multiple wavelets, shortlived meandering rotors, and figure-of-eight type reentries.
Ablation targeting the 5 NPAs was performed, and the AF inducibility vanished. After a 3-month blanking period, a recurrence of AF in the form of PAF rather than non-PAF was observed. Therefore, a second session was performed 11 months later and it was found that there was still no AF inducibility but reconnection of right superior and left superior pulmonary veins (PVs). Indeed, additional ablation to the PV reconnection sites was effective in maintaining sinus rhythm for 5 months after the second session. Such a clinical course might suggest that the NPA-targeted ablation in the first session was effective in at least modifying the AF maintenance mechanism.
| Case 5: Persistent AF
Case 5 was a 77-year-old male with non-PAF duration of 11 months.
This patient received both PVI and CTI ablation 9 years prior because of PAF and a second session 8 years prior for the PAF recurrence.
During the second session, both additional ablation of the reconnected PVs and that of a box isolation plus mitral isthmus block line were performed. However, 11 months before the third session (this session), AF in the form of non-PAF rather than PAF began.
As cardioversion did not terminate the AF, no voltage mapping was conducted before the NPA-targeted ablation. Thus, only simultaneous ExTRa and CFAE mapping was performed during the AF. It was then observed that only 2 of the 5 NPAs (areas with the top 5
highest %NP values) partially overlapped with CFAE areas, but 3 residual NPAs of the 5 NPAs did not overlap with obvious CFAE areas ( Figure 6A ). Figure 6B shows a snapshot of the phase map (Video S5) of one of the NPAs. In the NPA, a single counterclockwise rotational activation followed by short-lived meandering rotors and/or multiple wavelets was continuously observed. It is noteworthy that all 5 NPAs detected by the ExTRa Mapping were located outside the region of the box isolation ( Figure 6C ). In this case, only an NPA-guided ablation during AF was performed, and after the cardioversion, it was confirmed that there were no PV reconnections. After the last session, sinus rhythm was maintained during a 15-month follow-up period.
F I G U R E 4

| NPAs vs conventional indirect indicators of AF drivers
Because we experienced that catheter ablation targeting NPAs instead of LVAs or CFAE areas was effective in the above-mentioned 5 patients with non-PAF, we applied the same ablation procedure to the remaining patients with non-PAF. The phase map movies in all 28 patients with non-PAF who underwent ExTRa Mapping were analyzed, and the correlation between the NPAs and distribution of the LVAs and CFAE areas was investigated. Consequently, we found that the NPAs did not always coincide with LVAs or CFAE areas and that there was no significant correlation among them (P = .990 and P = .155, respectively).
| Outcome of the ExTRa Mapping-guided NPA ablation
The freedom from non-PAF/AT during the 8.1 AE 4.2-month followup of the ExTRa Mapping-guided NPA ablation in addition to PVI was 79%, which was markedly higher than that of the CFAE-targeted ablation in our hospital (47%, unpublished data). Furthermore, 
| Mechanisms on AF persistency in patients with non-PAF
Although it is accepted that functional reentry with a spiral-shaped wavefront, called rotor or spiral wave reentry, is involved in the mechanism of AF, the type of excitation wave dynamics leading to AF persistency is still unknown. Even for basic research, in terms of the excitation wave dynamics during AF, several hypotheses, that is, multiple wavelets, 7, 8 meandering rotors, 9 and stationary stable rotors, 10 have been proposed; therefore, it is natural that the mechanisms of non-PAF persistency in clinical practice are still unclear.
One of the main reasons for the difficulty in elucidating the mechanism of AF persistency in patients with non-PAF is that the optical mapping techniques 11, 12 commonly employed in animal
experiments cannot be applied to clinical practice because of both an invasive thoracotomy procedure and the toxicity of the voltagesensitive dye. Another reason is that existing high-density electroanatomical mapping systems cannot be applied to unstable random reentries during AF. Therefore, clinically available real-time AF imaging systems such as this ExTRa Mapping have long been sought.
In the present study, the ExTRa Mapping was applied to patients with non-PAF and as a result, other than the passively activated planar wave propagation, the typical non-PAF wave dynamics were rotational activations in the form of meandering rotors and/or multiple wavelets, as shown in Figures 1, 2C, 3C , 4C, 5C, and 6B (Videos S1 to S5). Indeed, such rotational activations, which were defined as NPAs, were effective ablation targets at least in most of our patients , and insufficient verification of the imaging algorithms, resulting from poor electrode contact 17 or constraints due to the inverse problem. 18 Moreover, those phase mapping systems are not currently available in our country, Japan.
F I G U R E 7
Kaplan-Meier estimates of freedom from non-PAF/ AT. Red line represents the ratio freedom from non-PAF/AT in all non-PAF patients (N = 49); the patients in whom ExTRa Mappingguided NPA ablation was performed because of AF inducibility after PVI, and in whom PVI only was performed because of no AF inducibility after the PVI. Black line denotes the ratio freedom from non-PAF/AT in the non-PAF patients in whom the ExTRa Mappingguided ablation was applied because of AF inducibility even after the PVI (N = 28)
On the other hand, the ExTRa Mapping online real-time AF imaging system complements the intra-atrial signals with a specialized artificial intelligence algorithm and provides a higher density imaging movie within a few seconds. In addition, a notable feature of the present system is that the phase map is based on myocardial action potentials, which are similar to experiments employing optical mapping systems, 11 whereas the phase maps produced by the aforementioned systems 14, 16 are based only on the timing of the excitation wavefront propagation.
| Comparison with extensive ablation
In this study, limited local ablation suggested the potential benefit beyond PVI. However, it is reported that extensive ablation, such as stepwise ablation, resulted in similar outcome to PVI. 19 A possible explanation about this discrepancy is that excessive extensive ablation eliminates most of the rotors, but at the same time, it stabilizes the remaining rotors, resulting in the cancelation of the additional benefits. Whereas, the ExTRa Mapping-guided NPA ablation might eliminate only a part of rotors but do not stabilize remaining rotors, thus likely to receive additional benefits.
| Study limitations
The novel phase mapping system employed in the present study might include some unknown limitations because the development of the system is still in progress. Although this system is not yet widely available even in Japan, we hope this system will spread to the world in the near future.
Although we directly observed the AF wave dynamics in realtime by applying our novel phase mapping system in patients with non-PAF, it was still very difficult to extract the real AF drivers from the various NPAs detected by our system. Although not all NPAs coincided with true AF drivers, we strongly believe that most NPAs with high %NP values contained, more or less, true AF drivers.
As this study was not randomized clinical trial, this study only suggested the potential benefit of NPA-targeted ablation beyond PVI.
Moreover, we did not perform right atrial mapping in the first session.
Nevertheless, the ablation outcome was much better than we expected.
Further studies are needed to elucidate these issues.
| CONCLUSIONS
Not all non-PAF drivers might be included in CFAE areas or LVAs.
To detect AF drivers during a non-PAF ablation, real-time imaging of the AF wave dynamics using ExTRa Mapping might be more useful than the conventional indirect indicators of AF drivers only.
